BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30403777)

  • 1. Elucidating the role of Agl in bladder carcinogenesis by generation and characterization of genetically engineered mice.
    Sottnik JL; Mallaredy V; Chauca-Diaz A; Ritterson Lew C; Owens C; Dancik GM; Pagliarani S; Lucchiari S; Moggio M; Ripolone M; Comi GP; Frierson HF; Clouthier D; Theodorescu D
    Carcinogenesis; 2019 Mar; 40(1):194-201. PubMed ID: 30403777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of Glycogen Debranching Enzyme AGL Drives Bladder Tumor Growth via Induction of Hyaluronic Acid Synthesis.
    Guin S; Ru Y; Agarwal N; Lew CR; Owens C; Comi GP; Theodorescu D
    Clin Cancer Res; 2016 Mar; 22(5):1274-83. PubMed ID: 26490312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High susceptibility of p53(+/-) knockout mice in N-butyl-N-(4-hydroxybutyl)nitrosamine urinary bladder carcinogenesis and lack of frequent mutation in residual allele.
    Ozaki K; Sukata T; Yamamoto S; Uwagawa S; Seki T; Kawasaki H; Yoshitake A; Wanibuchi H; Koide A; Mori Y; Fukushima S
    Cancer Res; 1998 Sep; 58(17):3806-11. PubMed ID: 9731488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dynamics of the inflammatory response during BBN-induced bladder carcinogenesis in mice.
    Degoricija M; Korac-Prlic J; Vilovic K; Ivanisevic T; Haupt B; Palada V; Petkovic M; Karaman I; Terzic J
    J Transl Med; 2019 Nov; 17(1):394. PubMed ID: 31779626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD44 and RHAMM are essential for rapid growth of bladder cancer driven by loss of Glycogen Debranching Enzyme (AGL).
    Oldenburg D; Ru Y; Weinhaus B; Cash S; Theodorescu D; Guin S
    BMC Cancer; 2016 Sep; 16(1):713. PubMed ID: 27595989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of uroplakin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats and mice.
    Ogawa K; St John M; Luiza de Oliveira M; Arnold L; Shirai T; Sun TT; Cohen SM
    Toxicol Pathol; 1999; 27(6):645-51. PubMed ID: 10588545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role in tumor growth of a glycogen debranching enzyme lost in glycogen storage disease.
    Guin S; Pollard C; Ru Y; Ritterson Lew C; Duex JE; Dancik G; Owens C; Spencer A; Knight S; Holemon H; Gupta S; Hansel D; Hellerstein M; Lorkiewicz P; Lane AN; Fan TW; Theodorescu D
    J Natl Cancer Inst; 2014 Apr; 106(5):. PubMed ID: 24700805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct mutations in the glycogen debranching enzyme found in glycogen storage disease type III lead to impairment in diverse cellular functions.
    Cheng A; Zhang M; Okubo M; Omichi K; Saltiel AR
    Hum Mol Genet; 2009 Jun; 18(11):2045-52. PubMed ID: 19299494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of p27 kip1 knockout mice to urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine may not simply be due to enhanced proliferation.
    Hikosaka A; Ogawa K; Sugiura S; Asamoto M; Takeshita F; Sato SY; Nakanishi M; Kohri K; Shirai T
    Int J Cancer; 2008 Mar; 122(6):1222-8. PubMed ID: 18027869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction of arsenic and N-butyl-N-(4-hydroxybutyl)nitrosamine on urothelial carcinogenesis in mice.
    Dai YC; Wang SC; Haque MM; Lin WH; Lin LC; Chen CH; Liu YW
    PLoS One; 2017; 12(10):e0186214. PubMed ID: 29016672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycogen storage disease type III: A novel Agl knockout mouse model.
    Pagliarani S; Lucchiari S; Ulzi G; Violano R; Ripolone M; Bordoni A; Nizzardo M; Gatti S; Corti S; Moggio M; Bresolin N; Comi GP
    Biochim Biophys Acta; 2014 Nov; 1842(11):2318-28. PubMed ID: 25092169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human glycogen debranching enzyme gene (AGL): complete structural organization and characterization of the 5' flanking region.
    Bao Y; Dawson TL; Chen YT
    Genomics; 1996 Dec; 38(2):155-65. PubMed ID: 8954797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analysis of the AGL gene: five novel mutations in GSD III patients.
    Lucchiari S; Donati MA; Melis D; Filocamo M; Parini R; Bresolin N; Comi GP
    Hum Mutat; 2003 Oct; 22(4):337. PubMed ID: 12955720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RGS6 is an essential tumor suppressor that prevents bladder carcinogenesis by promoting p53 activation and DNMT1 downregulation.
    Yang J; Platt LT; Maity B; Ahlers KE; Luo Z; Lin Z; Chakravarti B; Ibeawuchi SR; Askeland RW; Bondaruk J; Czerniak BA; Fisher RA
    Oncotarget; 2016 Oct; 7(43):69159-69172. PubMed ID: 27713144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conditional Expression of the Androgen Receptor Increases Susceptibility of Bladder Cancer in Mice.
    Johnson DT; Hooker E; Luong R; Yu EJ; He Y; Gonzalgo ML; Sun Z
    PLoS One; 2016; 11(2):e0148851. PubMed ID: 26862755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A c.3216_3217delGA mutation in AGL gene in Tunisian patients with a glycogen storage disease type III: evidence of a founder effect.
    Mili A; Ben Charfeddine I; Amara A; Mamaï O; Adala L; Ben Lazreg T; Bouguila J; Saad A; Limem K; Gribaa M
    Clin Genet; 2012 Dec; 82(6):534-9. PubMed ID: 22035446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for AGL ubiquitination in the glycogen storage disorders of Lafora and Cori's disease.
    Cheng A; Zhang M; Gentry MS; Worby CA; Dixon JE; Saltiel AR
    Genes Dev; 2007 Oct; 21(19):2399-409. PubMed ID: 17908927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-specific mutagenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine as the basis for urothelial carcinogenesis.
    He Z; Kosinska W; Zhao ZL; Wu XR; Guttenplan JB
    Mutat Res; 2012 Feb; 742(1-2):92-5. PubMed ID: 22155125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of a Functional Recombinant Human Glycogen Debranching Enzyme (hGDE) in N. benthamiana Plants and in Hairy Root Cultures.
    Rodriguez-Hernandez M; Triggiani D; Ivison F; Demurtas OC; Illiano E; Marino C; Franconi R; Massa S
    Protein Pept Lett; 2020; 27(2):145-157. PubMed ID: 31622193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A founder splice site mutation underlies glycogen storage disease type 3 in consanguineous Saudi families.
    Basit S; Malibari O; Al Balwi AM; Abdusamad F; Abu Ismail F
    Ann Saudi Med; 2014; 34(5):390-5. PubMed ID: 25827695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.